GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharmarise Holdings Corp (TSE:2796) » Definitions » Long-Term Debt

Pharmarise Holdings (TSE:2796) Long-Term Debt : 円9,654 Mil (As of May. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Pharmarise Holdings Long-Term Debt?

Pharmarise Holdings's Long-Term Debt for the quarter that ended in May. 2024 was 円9,654 Mil.

Pharmarise Holdings's quarterly Long-Term Debt increased from Nov. 2023 (円4,905 Mil) to Feb. 2024 (円8,300 Mil) and increased from Feb. 2024 (円8,300 Mil) to May. 2024 (円9,654 Mil).

Pharmarise Holdings's annual Long-Term Debt declined from May. 2022 (円7,085 Mil) to May. 2023 (円5,216 Mil) but then increased from May. 2023 (円5,216 Mil) to May. 2024 (円9,654 Mil).


Pharmarise Holdings Long-Term Debt Historical Data

The historical data trend for Pharmarise Holdings's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmarise Holdings Long-Term Debt Chart

Pharmarise Holdings Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,546.00 7,432.00 7,085.00 5,216.00 9,654.00

Pharmarise Holdings Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,216.00 5,327.00 4,905.00 8,300.00 9,654.00

Pharmarise Holdings  (TSE:2796) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Pharmarise Holdings Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Pharmarise Holdings's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmarise Holdings Business Description

Traded in Other Exchanges
N/A
Address
8 Floor, Sumitomo Nakano Sakue Building, 1-38-1 Chuo, Nakano-ku, Tokyo, JPN, 164-0011
Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.

Pharmarise Holdings Headlines

No Headlines